Galcanezumab Completed Phase 4 Trials for Episodic Migraine / Migraine Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 4 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT05127486 | A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine |